Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hip liner tracked for 10 years: will it last?

NCT ID NCT07150221

ENROLLING_BY_INVITATION Disease control Sponsor: Zimmer Biomet Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025

Summary

This study follows 52 people who already received a Vivacit-E hip liner during total hip replacement. Researchers will track how long the implant lasts and any problems over 10 years. The goal is to confirm the liner is safe and helps reduce pain and improve movement for conditions like arthritis or hip injury.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRAUMATIC ARTHROPATHY-HIP are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • South Bend Orthopaedics

    South Bend, Indiana, 46635, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Vivacit-E Vitamin E highly crosslinked polyethylene elevated liner (a medical device used in hip replacement surgery)

What this could lead to

If successful, this study could confirm that the Vivacit-E liner is safe and works well for at least 10 years, helping people with hip pain move better.

What could go wrong

This is a small, observational study with only 52 people, so results may not apply to everyone. The device could still fail or cause complications over time.

Conditions

The condition(s) this trial relates to.

avascular necrosis diastrophic dysplasia epiphysiolysis of the hip hip fracture osteoarthritis osteoarthritis, hip Protrusio acetabuli

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.